Monitoring the personalized effects of antihypertensive drugs using the Aktiia optical device: a 4-month follow-up
- Authors
-
- Josep Sola, Aktiia SA, Neuchâtel
- Sibylle Fallet, Aktiia SA, Neuchâtel
- Gregoire Wuerzner, SWITZERLAND
- DOI
- 10.4414/CVM.2021.w10054